Shree Ganesh Rem Stock Price Today (NSE: 540737)
Fundamental Score
Shree Ganesh Rem Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Shree Ganesh Rem share price today is ₹703.80, down 2.17% on NSE/BSE as of 22 September 2026. Shree Ganesh Rem (540737) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹903.51 (Cr). The 52-week high for 540737 share price is ₹759.00 and the 52-week low is ₹381.10. At a P/E ratio of 58.50x, 540737 is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 11.53% and a debt-to-equity ratio of 0.19.
Shree Ganesh Rem Share Price Chart — NSE/BSE Historical Performance
Shree Ganesh Rem share price chart: -19.00% return over the past month. 52-week high ₹759.00, 52-week low ₹381.10.
Shree Ganesh Rem — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹520.00 | ₹528.10 | ₹510.00 | ₹518.70 | 2.88K (Cr) | |
| ₹515.50 | ₹524.50 | ₹500.30 | ₹517.30 | 2.07K (Cr) | |
| ₹526.15 | ₹526.20 | ₹490.25 | ₹506.20 | 2.07K (Cr) | |
| ₹509.00 | ₹520.00 | ₹507.40 | ₹518.75 | 1.42K (Cr) | |
| ₹501.65 | ₹514.75 | ₹493.00 | ₹506.40 | 6.57K (Cr) | |
| ₹522.60 | ₹522.60 | ₹501.05 | ₹501.65 | 6.68K (Cr) | |
| ₹526.25 | ₹528.95 | ₹512.00 | ₹522.65 | 3.73K (Cr) | |
| ₹533.10 | ₹541.70 | ₹521.00 | ₹526.25 | 2.83K (Cr) | |
| ₹495.05 | ₹557.95 | ₹493.30 | ₹533.15 | 24.64K (Cr) | |
| ₹530.55 | ₹530.55 | ₹476.75 | ₹490.40 | 41.59K (Cr) |
Shree Ganesh Rem — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹635.00 | ₹662.00 | ₹476.75 | ₹518.70 | -18.31% | |
| ₹639.30 | ₹715.00 | ₹600.00 | ₹633.00 | -0.99% | |
| ₹648.00 | ₹759.00 | ₹526.65 | ₹635.25 | -1.97% | |
| ₹482.15 | ₹665.00 | ₹480.05 | ₹649.35 | +34.68% | |
| ₹430.00 | ₹551.00 | ₹425.00 | ₹514.65 | +19.69% | |
| ₹505.00 | ₹590.00 | ₹414.00 | ₹420.05 | -16.82% | |
| ₹419.05 | ₹548.00 | ₹412.05 | ₹512.20 | +22.23% | |
| ₹461.40 | ₹481.35 | ₹381.10 | ₹417.95 | -9.42% | |
| ₹467.45 | ₹480.20 | ₹418.00 | ₹463.20 | -0.91% | |
| ₹499.90 | ₹499.90 | ₹442.10 | ₹467.45 | -6.49% | |
| ₹513.90 | ₹535.00 | ₹478.50 | ₹496.00 | -3.48% | |
| ₹552.00 | ₹560.75 | ₹494.95 | ₹513.90 | -6.90% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Shree Ganesh Rem Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Shree Ganesh Rem Fundamental Analysis & Valuation Benchmarking
Educational evaluation of 540737 across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (15.16%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (31.09%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (17.38% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.19)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.05x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 3.96)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (72.84%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Premium Valuation Risk (P/E: 58.50x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (5.54x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Profit Decline Concern (-67.49%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-41.79%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-19.97 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Shree Ganesh Rem vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Shree Ganesh Rem with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
49.4/100 | ₹703.80₹704 | ₹903.51₹903.51 | 58.50Average 58.5 Average | 11.53%Average 11.53% Average | 15.16%Good 15.16% Good | 0.19Excellent 0.2 Excellent | 12.76%Good 12.76% Good | 17.38%Excellent 17.38% Excellent | 0.00% | |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1861.50₹1862 | ₹446629.70₹446629.70 | 36.93Average 36.9 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9423.00₹9423 | ₹249709.50₹249709.50 | 85.50Average 85.5 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4965.50₹4966 | ₹168062.31₹168062.31 | 79.32Average 79.3 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1126.70₹1127 | ₹112444.66₹112444.66 | 25.11Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1370.50₹1371 | ₹110715.84₹110715.84 | 32.83Average 32.8 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1943.50₹1944 | ₹104997.59₹104997.59 | 95.93Average 95.9 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1668.50₹1669 | ₹96005.49₹96005.49 | 26.07Average 26.1 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1139.50₹1140 | ₹95148.25₹95148.25 | 29.45Average 29.5 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2079.30₹2079 | ₹95075.99₹95075.99 | 17.18Average 17.2 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2270.30₹2270 | ₹93763.39₹93763.39 | 45.87Average 45.9 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price446629.70 Cr
- Divi's Laboratories Limited share price249709.50 Cr
- Torrent Pharmaceuticals Limited share price168062.31 Cr
- Zydus Lifesciences Limited share price112444.66 Cr
- Cipla Limited share price110715.84 Cr
Shree Ganesh Rem Quarterly Performance
Latest quarterly metrics for 540737 — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-41.79%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-67.49%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
17.38%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
12.76%
Compounded annual net profit growth over 5 years
Shree Ganesh Rem Technical Indicators
SMA 50, SMA 200, RSI and volume signals for 540737 — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Shree Ganesh Rem Financial Statements
Annual income statement, balance sheet and cash flow for Shree Ganesh Rem (540737) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Shree Ganesh Rem
About 540737 (Shree Ganesh Rem)
Shree Ganesh Rem (540737) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current... market capitalisation of ₹903.51 (Cr). Shree Ganesh Rem has delivered a Return on Equity (ROE) of 11.53% and a ROCE of 15.16%. The debt-to-equity ratio stands at 0.19, reflecting the company's capital structure. Investors tracking 540737 share price can monitor key metrics including P/E ratio, promoter holding of 72.84%, and quarterly earnings growth.
Company Details
540737 Share Price: Frequently Asked Questions
What is the current share price of Shree Ganesh Rem?
Shree Ganesh Rem (540737) trades at ₹703.80 on BSE. Market cap ₹903.51 (Cr). Educational data only.
What is the P/E ratio of Shree Ganesh Rem?
Shree Ganesh Rem has a P/E of 58.50x vs industry average 34.89x.
What is the Bull Run score for Shree Ganesh Rem?
Shree Ganesh Rem has a Bull Run score of 49.4/100 based on 25+ financial parameters.
Does Shree Ganesh Rem pay dividends?
Shree Ganesh Rem has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Shree Ganesh Rem?
Shree Ganesh Rem has ROE of 11.53%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Shree Ganesh Rem?
Shree Ganesh Rem has debt-to-equity of 0.19.
Is Shree Ganesh Rem a good investment?
Bull Run gives Shree Ganesh Rem a score of 49.4/100. This is not investment advice — consult a SEBI-registered advisor.